LEUKAEMIA MICROENVIRONMENT & HIGH RISK CHILDHOOD LEUKAEMIA
With
Associate Professor Laurence Cheung
Curtin University
& Research Lead, Curtin Medical Research Institute,
Western Australia &
Research Lead,
The Kids Research Institute,
Western Australia
RESEARCHER PROFILE
Filmed in Perth, Western Australia | February 2026
Associate Professor Laurence Cheung is an exemplary pharmacist-scientist whose research is focused on improving outcomes in children with high-risk leukaemia.
He obtained his Bachelor of Pharmacy degree with First Class Honours from the Curtin University in 2000 and have been a registered pharmacist since 2001. In 2014, he completed the PhD studies at The Kids Research Institute Australia (The Kids) in the area of haematopoiesis and paediatric leukaemia.
He is now an Associate Professor at the Curtin Medical School as well as Curtin Medical Research Institute, and a Co-head of the Leukaemia Translational Research Laboratory at The Kids.
He has attracted over $8.7 million in research funding, including 16 awards as CIA (over $6.1 million). Assoc Prof Cheung was named the 2019 Cancer Council of WA Early Career Cancer Researcher of the Year and received the STEM Early Career Research Award at Curtin University in 2019.
Assoc Prof Cheung enjoys nurturing and motivating the next generation scientists and HDR students and he believes that the true success is about influencing others to achieve their own greatness.
He has supervised two PhD and one Masters students to completion, and is currently supervising 4 PhD students as a Primary Supervisor. In 2023, Assoc Prof Cheung received the Faulty of Health Sciences Teaching Excellence Individual Award for Honours, Postgraduate, or HDR supervision at Curtin University.
Funding sources include: Toby for Childhood Cancer, Cancer Council Western Australia, WA Government
Source: Supplied and adapted
You Might also like
-
Dr Paul Griffin
MATER HEALTH SERVICES, QUEENSLAND, AUSTRALIA
-
Dr Venkata Tarigoppula
RESEARCH IN BRAIN COMPUTER INTERFACE
@ SYNCHRON
MELBOURNE, VICTORIA, AUSTRALIA -
Identification & characterisation of molecular drivers of therapeutic resistance
Professor Pieter Eichhorn is an internationally experienced cancer biologist and research leader whose career has been defined by high-impact contributions at the interface of functional genomics, translational oncology, and research infrastructure strategy.
He completed his PhD at the University of Newcastle upon Tyne, contributing to the cloning of the gene associated with Cornelia de Lange Syndrome, before undertaking postdoctoral training at the Netherlands Cancer Institute in the laboratory of René Bernards. There, he performed pioneering functional genetic screens that identified key regulators of oncogenesis and therapy resistance, including critical roles for the PI3K signalling pathway in resistance to targeted breast cancer therapies.
https://orcid.org/0000-0001-6298-5288